Kennosuke
Itoh
*ab,
Hiroki
Nakahara
a,
Atsushi
Takashino
a,
Aya
Hara
a,
Akiho
Katsuno
a,
Yuriko
Abe
a,
Takaaki
Mizuguchi
ab,
Fumika
Karaki
ab,
Shigeto
Hirayama
ab,
Kenichiro
Nagai
b,
Reiko
Seki
b,
Noriko
Sato
b,
Kazuki
Okuyama
c,
Masashi
Hashimoto
c,
Ken
Tokunaga
d,
Hitoshi
Ishida
e,
Fusako
Mikami
f,
Kofi Dadzie
Kwofie
f,
Hayato
Kawada
f,
Bangzhong
Lin
g,
Kazuto
Nunomura
g,
Toshio
Kanai
g,
Takeshi
Hatta
f,
Naotoshi
Tsuji
f,
Junichi
Haruta
g and
Hideaki
Fujii
ab
aLaboratory of Medicinal Chemistry, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan. E-mail: itok@pharm.kitasato-u.ac.jp
bMedicinal Research Laboratories, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan
cDepartment of Material Science, Graduate School of Science, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan
dDivision of Liberal Arts, Center for Promotion of Higher Education, Kogakuin University, 2665-1 Nakano-machi, Hachioji, Tokyo 192-0015, Japan
eGraduate School of Science and Engineering, Department of Chemistry, Materials and Bioengineering, Kansai University, 3-3-35 Yamate-cho, Suita, Osaka 564-8680, Japan
fDepartment of Parasitology and Tropical Medicine, Kitasato University School of Medicine, 1-15-1 Kitazato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan
gDrug Innovation Center Lead Exploration Unit, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadagaoka, Suita, Osaka 565-0871, Japan
First published on 24th October 2024
Correction for ‘Anti-schistosomal activity and ADMET properties of 1,2,5-oxadiazinane-containing compound synthesized by visible-light photoredox catalysis’ by Kennosuke Itoh et al., RSC Med. Chem., 2024, https://doi.org/10.1039/d4md00599f.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2024 |